• O. S. Nykonenko SI “Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine”
Keywords: vitamin D3, atherosclerosis, endothelial dysfunction


Vitamin D3 deficiency is common worldwide (Holick, 2006) (1). For example, vitamin D3 deficiency was 77% in the US population (Ginde et al., 2009) (2). According to our data, vitamin D3 deficiency was found in 80% of CHD patients (3). Ecological studies have shown a higher incidence of cardiovascular disease with increasing distance from the equator, suggesting an association with vitamin D insufficiency in regions with less sun exposure (4). Low 25(OH)D concentrations may increase the risk of hypertension, peripheral vascular disease, diabetes, obesity, myocardial infarction, heart failure, and cardiac mortality (4,5,6,7), low 25(OH)D levels are associated with endothelial dysfunction, inflammation, increased vascular stiffness and arterial calcification (8).


Holick MF. High Prevalence of Vitamin D Inadequacy and Implications for Health. Mayo Clinic Proceedings [Internet]. 2006;81(3):353-373. Available from: doi:10.4065/81.3.353.

Ginde AA, Liu MC, Camargo CA. Demographic Differences and Trends of Vitamin D Insufficiency in the US Population, 1988-2004. Archives of Internal Medicine [Internet]. 2009;169(6):626. Available from: doi:10.1001/archinternmed.2008.604.

Nikonenko OS, Nikonenko AO, Chmul KO, Molodan OV, Osaulenko VV. Study of the Functional State of the Left Ventricular Myocardium in Patients with Coronary Artery Disease with Impaired Metabolism of Homocysteine and Vitamin D. Ukrainian journal of cardiovascular surgery [Internet]. 2020:62-68. Available from: doi:10.30702/ujcvs/20.3803/014062-068.

Fleck A. Latitude and ischaemic heart disease. The Lancet [Internet]. 1989;333(8638):613. Available from: doi:10.1016/s0140-6736(89)91634-6.

Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nature Reviews Immunology [Internet]. 2006;6(7):508-519. Available from: doi:10.1038/nri1882..

Lavie CJ, Lee JH, Milani RV. Vitamin D and Cardiovascular Disease. Journal of the American College of Cardiology [Internet]. 2011;58(15):1547-1556. Available from: doi:10.1016/j.jacc.2011.07.008.

Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, et al. Prevalence of Cardiovascular Risk Factors and the Serum Levels of 25-Hydroxyvitamin D in the United States. Archives of Internal Medicine [Internet]. 2007;167(11):1159. Available from: doi:10.1001/archinte.167.11.1159.

Giovannucci E. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Archives of Internal Medicine [Internet]. 2008;168(11):1174. Available from: doi:10.1001/archinte.168.11.1174..

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism [Internet]. 2011;96(7):1911-1930. Available from: doi:10.1210/jc.2011-0385.

Carthy EP, Yamashita W, Hsu A, Ooi BS. 1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth. Hypertension [Internet]. 1989;13(6_pt_2):954-959. Available from: doi:10.1161/01.hyp.13.6.954.

Shioi A, Katagi M, Okuno Y, Mori K, Jono S, Koyama H, et al. Induction of Bone-Type Alkaline Phosphatase in Human Vascular Smooth Muscle Cells. Circulation Research [Internet]. 2002;91(1):9-16. Available from: doi:10.1161/01.res.0000026421.61398.f2.

Nibbelink KA, Tishkoff DX, Hershey SD, Rahman A, Simpson RU. 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. The Journal of Steroid Biochemistry and Molecular Biology [Internet]. 2007;103(3-5):533-537. Available from: doi:10.1016/j.jsbmb.2006.12.099.

Rigby WF, Stacy T, Fanger MW. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). Journal of Clinical Investigation [Internet]. 1984;74(4):1451-1455. Available from: doi:10.1172/jci111557.

Wakasugi M, Noguchi T, Inoue M, Kazama Y, Tawata M, Kanemaru Y, et al. Vitamin D3 stimulates the production of prostacyclin by vascular smooth muscle cells. Prostaglandins [Internet]. 1991;42(2):127-136. Available from: doi:10.1016/0090-6980(91)90072-n.

Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Current Opinion in Pharmacology [Internet]. 2010;10(4):482-496. Available from: doi:10.1016/j.coph.2010.04.001.

Siasos G, Tousoulis D, Oikonomou E, Maniatis K, Kioufis S, Kokkou E, et al. Vitamin D serum levels are associated with cardiovascular outcome in coronary artery disease. International Journal of Cardiology [Internet]. 2013;168(4):4445-4447. Available from: doi:10.1016/j.ijcard.2013.06.151.

Schierbeck LL, Jensen TS, Bang U, Jensen G, Køber L, Jensen JB. Parathyroid hormone and vitamin D-markers for cardiovascular and all cause mortality in heart failure. European Journal of Heart Failure [Internet]. 2011;13(6):626-632. Available from: doi:10.1093/eurjhf/hfr016.

Akin F, Ayça B, Köse N, Duran M, Sarı M, Uysal OK, et al. Serum Vitamin D Levels Are Independently Associated With Severity of Coronary Artery Disease. Journal of Investigative Medicine [Internet]. 2012;60(6):869-873. Available from: doi:10.2310/jim.0b013e31825457cb.

Lai H, Fishman EK, Gerstenblith G, Brinker JA, Tong W, Bhatia S, et al. Vitamin D deficiency is associated with significant coronary stenoses in asymptomatic African American chronic cocaine users. International Journal of Cardiology [Internet]. 2012;158(2):211-216. Available from: doi:10.1016/j.ijcard.2011.01.032.

Libby P. Inflammation in atherosclerosis. Nature [Internet]. 2002;420(6917):868-874. Available from: doi:10.1038/nature01323.

Al IM, Patel R, Murrow J, Morris A, Rahman A, Fike L, et al. Vitamin D Status Is Associated With Arterial Stiffness and Vascular Dysfunction in Healthy Humans. Journal of the American College of Cardiology [Internet]. 2011;58(2):186-192. Available from: doi:10.1016/j.jacc.2011.02.051.

Walski M, Chlopicki S, Celary-Walska R, Frontczak-Baniewicz M. Ultrastructural alterations of endothelium covering advanced atherosclerotic plaque in human carotid artery visualised by scanning electron microscope. J Physiol Pharmacol. 2002;53(pt 1):713–723.

Vanhoutte P. Endothelial dysfunction and atherosclerosis. European Heart Journal [Internet]. 1997;18:E19-E29. Available from: doi:10.1016/s0195-668x(97)90005-1.

Molinari C, Uberti F, Grossini E, Vacca G, Carda S, Invernizzi M, et al. 1α,25-Dihydroxycholecalciferol Induces Nitric Oxide Production in Cultured Endothelial Cells. Cellular Physiology and Biochemistry [Internet]. 2011;27(6):661-668. Available from: doi:10.1159/000330075.

Queen LR, Ji Y, Xu B, Young L, Yao K, Wyatt AW, et al. Mechanisms underlying β2-adrenoceptor-mediated nitric oxide generation by human umbilical vein endothelial cells. The Journal of Physiology [Internet]. 2006;576(2):585-594. Available from: doi:10.1113/jphysiol.2006.115998.

Doran AC, Meller N, McNamara CA. Role of Smooth Muscle Cells in the Initiation and Early Progression of Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology [Internet]. 2008;28(5):812-819. Available from: doi:10.1161/atvbaha.107.159327.

Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE. 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circulation Research [Internet]. 2000;87(3):214-220. Available from: doi:10.1161/01.res.87.3.214.

Artaza JN, Norris KC. Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. Journal of Endocrinology [Internet]. 2008;200(2):207-221. Available from: doi:10.1677/joe-08-0241.

Ha H, Oh EY, Lee HB. The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases. Nature Reviews Nephrology [Internet]. 2009;5(4):203-211. Available from: doi:10.1038/nrneph.2009.15.

Libby P, Ridker PM, Maseri A. Inflammation and Atherosclerosis. Circulation [Internet]. 2002;105(9):1135-1143. Available from: doi:10.1161/hc0902.104353.

Simon A, Chironi G, Megnien J. Relevance of Screening Symptom-Free Population for Coronary and Noncoronary Calcification Burden. Hypertension [Internet]. 2010;55(4):840-841. Available from: doi:10.1161/hypertensionaha.109.148981.

Speer MY, Yang H, Brabb T, Leaf E, Look A, Lin W, et al. Smooth Muscle Cells Give Rise to Osteochondrogenic Precursors and Chondrocytes in Calcifying Arteries. Circulation Research [Internet]. 2009;104(6):733-741. Available from: doi:10.1161/circresaha.108.183053.

Hsu JJ, Tintut Y, Demer LL. Vitamin D and Osteogenic Differentiation in the Artery Wall. Clinical Journal of the American Society of Nephrology [Internet]. 2008;3(5):1542-1547. Available from: doi:10.2215/cjn.01220308.

Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, et al. Active Serum Vitamin D Levels Are Inversely Correlated With Coronary Calcification. Circulation [Internet]. 1997;96(6):1755-1760. Available from: doi:10.1161/01.cir.96.6.1755.

Braam L, Hoeks A, Brouns F, Hamulyák K, Gerichhausen M, Vermeer C. Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thrombosis and Haemostasis [Internet]. 2004;91(02):373-380. Available from: doi:10.1160/th03-07-0423.

Doherty TM, Tang W, Dascalos S, Watson KE, Demer LL, Shavelle RM, et al. Ethnic origin and serum levels of 1alpha,25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. Circulation [Internet]. 1997;96(5):1477-1481. Available from: doi:10.1161/01.cir.96.5.1477.

McCullough PA, Sandberg KR, Dumler F, Yanez JE. Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review. J Nephrol. 2004;17:205–215.

Shioi A, Morioka T, Shoji T, Emoto M. The Inhibitory Roles of Vitamin K in Progression of Vascular Calcification. Nutrients [Internet]. 2020;12(2):583. Available from: doi:10.3390/nu12020583.

Satilmis S, Celik O, Biyik I, Ozturk D, Celik K, Akın F, et al. Association between serum vitamin D levels and subclinical coronary atherosclerosis and plaque burden/composition in young adult population. Bosnian Journal of Basic Medical Sciences [Internet]. 2015;15(1). Available from: doi:10.17305/bjbms.2015.238.

How to Cite
Nykonenko, O. S. (2022). VITAMIN D3 AS A HORMONE - THE ROLE IN THE DEVELOPMENT OF ATHEROSCLEROSIS. Modern Medical Technology, (3(54), 10-14.
Original research